Migraine ophthalmique with reversible scotomas after sclerotherapy with liquid 1% polidocanol

Dermatologic Surgery

Volumn 32, Issue 11, 2006, Pages 1410-1413

  Künzlberger, Beate ^a   Pieck, Carsten ^b   Altmeyer, Peter ^a   Stücker, Markus ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b Praxis of Dermatology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; POLIDOCANOL;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; DIZZINESS; FEMALE; HEADACHE; HEMIANOPIA; HUMAN; MIGRAINE; NEUROLOGIC EXAMINATION; OPHTHALMOLOGY; PRIORITY JOURNAL; SCLEROTHERAPY; SCOTOMA; SPIDER VEIN; VEIN STRIPPING; VISUAL IMPAIRMENT;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMIANOPSIA; HUMANS; LEG; MIGRAINE DISORDERS; NEUROLOGIC EXAMINATION; POLYETHYLENE GLYCOLS; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SCOTOMA; TELANGIECTASIS; VISUAL ACUITY;

EID: 33750631632     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2006.32314.x     Document Type: Article

References (7)

1. Duffy DM. Small vessel sclerotherapy: an overview. Adv Dermatol 1988;3:221-42.
2. Conrad P, Malouf GM. The Australian polidocanol (aethoxysklerol) study: results at 2 years. Dermatol Surg 1995;21:334-6.
3. Goldman MP. Sclerotherapy treatment of varicose and teleangiectatic leg veins, 3rd ed. St. Louis: Mosby Year Book, 1995.
4. Feied CF, Jackson JJ, Bren TS, et al. Allergic reactions to polidocanol for vein sclerosis. J Dermatol Surg Oncol 1994;20:466-8.
5. Benigni JP, Ratinahirana H, Bousser MG. Polidocanol 400 foam injection and migraine with visual aura [abstract]. ACP 16th Annual Congress; Nov. 7-10, 2002; Ft. Lauderdale, FL.
6. Bücking H, Baumgartner G. Klinik und pathophysiologie der initialen neurologischen symptome bei fokalen migränen. Arch Psychiatr Nervenkr 1974;219:37-52.
7. Kanter A. Clinical determinants of ultrasound-guided sclerotherapy. Dermatol Surg 1998;24:138-40.